The Informed Consent Action Network (ICAN) has uncovered a marketing and branding change for one of the developers of “self-spreading vaccines.” Autonomous Therapeutics previously said they develop “artificial immune systems that are inhalable and variant-proof —using a new class of RNA, known as encrypted RNA™.” The company’s website has now updated the front page summary to say they develop “precision medicines that are disease-activated and resistance-proof. We use a new class of RNA, known as encRNA.”

ICAN has been sounding the alarm about the serious potential threat these “inhalable” vaccines pose to the public who would be exposed without knowledge and consent. The organization believes the marketing slogan change is a result of increased attention from the segment that appeared on The HighWire. 

Dr. Ariel Weinberger, the CEO and founder of Autonomous Therapeutics, and Dr. Timothy Notton, the chief scientific officer, co-authored a paper in 2014 making the case for “transmissible antivirals to control population-wide infectious diseases.” They consider transmissible vaccines a way to “therapeutically target the highest-risk populations, circumvent behavioral barriers, and overcome pathogen persistence and resistance mechanisms.”

“Behavioral barriers” refer to the lack of vaccine uptake by members of the public that are deemed to be “vaccine hesitant.” In the aftermath of the COVID-19 pandemic and Operation Warp Speed, there has been a notable increase in vaccine skepticism. That is the basis for the stunning admissions of insufficient safety and efficacy studies by the Godfather of Vaccines, Stanley Plotkin, which was reported by The HighWire earlier this month.

The COVID-19 origin discussion is still in full force, as the Select Subcommittee on the Coronavirus Pandemic has questioned public health officials about the risky gain-of-function research at the Wuhan Institute of Virology, which was a likely source for the virus that sparked the global pandemic. The Highwire interviewed Justin Goodman of the White Coat Waste Project and Biologist Dr. Bryce Nickels about the risks of this research, and they both said the only purpose of doing this laboratory research is to create bio-weapons.

Vaccine hesitancy has increased partly as a result of public health officials trying to cover up the dangerous research in Wuhan. The Defense Advanced Research Projects Agency (DARPA) is responsible for developing technologies for use by the military. DARPA has been funding gain-of-function research on dangerous viruses, and they are also giving millions of dollars to Autonomous Therapeutics to study and bring “inhalable, self-spreading” vaccines to the market.

Autonomous Therapeutics also highlights Dr. Notton’s inclusion on a list of scientists named as “DARPA Risers” during the 60th anniversary of the agency. His work with “inhalable” lipid nanoparticle platforms is also mentioned on his website bio.

The website touts partnerships with DARPA, the Department of Defense, and the NIH. It also lists IQT, as a “top investor in defense and national security startups. IQT mentions its government partnerships on its website. “IQT’s unique approach pairing high-tech problem solvers with government challenges has produced countless impactful solutions for the CIA; DIA; FBI; NGA; NRO; NSA; DHS (including CBP and other DHS components); U.S. Cyber Command; and the U.K. and Australian national intelligence communities. We recently welcomed the Office of Naval Research (ONR), U.S. Central Command, and U.S. Space Force as new government partners and look forward to supporting their missions too.”

Another partnership is Blue Knight, described as “This joint initiative was created between Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services. Blue Knight is a collaboration dedicated to anticipating potential health security threats, activating the global innovation community, and amplifying scientific and technological advancements with the aim of preparing for and responding to our rapidly evolving global health environment.”

Several government agencies are involved with pushing this technology forward, and Congress also passed the PREVENT Pandemics Act, which allows the “development and review of new treatments and countermeasures that use cutting-edge, adaptable platform technologies that can be incorporated or used in more than one drug or biological product.”

An ICAN press release from February states, “This Act will also be used to fund a new HHS government agency called ARPA-H (Advanced Research Projects Agency for Health), which was created in 2023 to “take big technical risks that can spark new biomedical breakthroughs” and “revolutionize the detections, diagnosis, mitigation, prevention, treatment and cure of diseases and health conditions.” Both former NIH Director Francis Collins and HHS Secretary Xavier Becerra supported the agency’s creation, and Collins described his vision for ARPA-H as “a DARPA-like culture at NIH.””

Former HHS Director Tevi Troy is on the board for Autonomous Therapeutics and wrote a “guest commentary” article for BioCentury.com arguing that “warp speed isn’t fast enough” and that there is an urgent need for variant-proof therapeutics.

VxBiosciences is the other primary company working on this technology in collaboration with the J. David Gladstone Institutes, led by Leor Weinberger, Ariel’s brother. Leor Weinberger has also conducted studies alongside his brother and “served on the Bill and Melinda Gates Foundation review panel.” Weinberger is currently suing VxBiosciences for breach of contract.

VxBiosciences received $4.8 million from the HHS to develop a “new paradigm for pandemic prevention.” The project description states that the co-evolving, replicating, and self-renewing SARS-COV2 therapies are needed to “circumvent compliance issues.” The therapy will be part of a “co-evolutionary arms race, co-evolving with wild-type virus to overcome resistance.” The innovative therapy would “surmount the universal barriers to pandemic control and lower prevalence for many viruses below levels achievable by vaccination or antiviral therapy campaigns.” The therapy will “utilize superspreaders to deploy the intervention.”

The ICAN attorneys are attempting to gather more information from federal agencies. Through FOIA requests, they have requested information from DARPA, DOI, the Navy, and NIH.

 

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

Former Gov. Andrew Cuomo Referred to DOJ for Alleged Lies to Congress on COVID Nursing Home Policy

The Select Subcommittee on the Coronavirus Pandemic has referred former New York Governor Andrew Cuomo to the DOJ (Department of Justice) for criminal prosecution. The committee’s X page said, “Evidence suggests Andrew Cuomo knowingly and willfully made materially false statements about New York’s COVID-19 nursing home disaster and the ensuing cover-up.” The letter signed byContinue reading Former Gov. Andrew Cuomo Referred to DOJ for Alleged Lies to Congress on COVID Nursing Home Policy

More news about Coronavirus

Health & Nutrition

Trump Names RFK Jr. HHS Secretary In New Administration

President Donald J. Trump selected Robert F. Kennedy Jr. to be the Secretary of Health and Human Services (HHS), which includes oversight of the FDA, CDC, and NIH among other important federal health agencies. There have been mixed reactions following the announcement, which follows Trump and Kennedy’s campaign promise to make America healthy again. PresidentContinue reading Trump Names RFK Jr. HHS Secretary In New Administration

More news about Health & Nutrition

Vaccines

COVID-19 Vaccine Marketing Campaign Not Supported By Scientific Evidence, House Report Reveals

A 113-page House report was released last week regarding the Department of Health and Human Services’ (HHS) response to the COVID-19 pandemic. Specifically, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations evaluated the “effectiveness and scientific accuracy of the “We Can Do This” COVID-19 vaccine promotional campaign that ran from AugustContinue reading COVID-19 Vaccine Marketing Campaign Not Supported By Scientific Evidence, House Report Reveals

More news about Vaccines

Science & Tech

Nearly Three-Quarters of Immunologist Peer Reviewers Receive Payments From Industry

Most peer reviewers receive research funds and other payments from the industry, according to new research published in The Journal of the American Medical Association (JAMA). The peer review process has long been considered necessary to ensure the study is trustworthy and replicable. The latest publication provides data on financial incentives for peer reviewers in theContinue reading Nearly Three-Quarters of Immunologist Peer Reviewers Receive Payments From Industry

More news about Science & Tech

Environment

USDA Approves Deregulation of GMOs with Up to 12 Genetic Modifications

The USDA’s Animal and Plant Health Inspection Service (APHIS) has now deregulated certain GMO crops, allowing plants with up to 12 genetic modifications to bypass regulatory oversight if these modifications could theoretically be achieved through conventional breeding methods. APHIS published the final notice on Wednesday, noting that it received 6,500 comments regarding the proposal. TheContinue reading USDA Approves Deregulation of GMOs with Up to 12 Genetic Modifications

More news about Environment

Policy

Department of Government Efficiency Looks to Cut Wasteful Federal Spending With “Historic Opportunity”

President-elect Donald Trump announced the creation of the Department of Government Efficiency (DOGE) which Elon Musk and Vivek Ramaswamy will lead. The goal of this department is to reduce wasteful government spending and simplify the language of regulations. Musk has promised transparency and weekly updates regarding any proposed cuts to government spending. Senator Rand Paul,Continue reading Department of Government Efficiency Looks to Cut Wasteful Federal Spending With “Historic Opportunity”

More news about Policy